Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Oncology

Understanding Diffuse Gastric Adenocarcinoma

At a Glance

Diffuse gastric adenocarcinoma is an aggressive stomach cancer that spreads silently through the stomach wall rather than forming a visible lump. This makes it hard to diagnose during a standard endoscopy. Key signs include indigestion, mild nausea, and feeling full after eating very little.

Finding out you have diffuse gastric adenocarcinoma can be overwhelming, especially because it behaves differently than many other types of cancer. Most stomach cancers form a solid lump or tumor that grows into the open space of the stomach. In contrast, the diffuse type is “stealthy”—it spreads like a carpet through the layers of the stomach wall rather than forming a single, easy-to-see mass [1][2].

Understanding the Two Main Types

Doctors use a tool called the Lauren classification to divide stomach cancers into two main categories: intestinal-type and diffuse-type [3][4].

  • Intestinal-Type: These tumors often look like a distinct lump or an ulcer. They are frequently linked to chronic inflammation or H. pylori infections and generally have a better long-term outlook [5][6].
  • Diffuse-Type: These cancers are characterized by individual cells or small groups of cells that scatter throughout the stomach tissue [4]. This type is considered more aggressive and is often harder to detect in its early stages [7][8].

The Biology: Why It Spreads Differently

The primary reason diffuse gastric cancer behaves this way is a “glitch” in the cells’ “glue.” Most of these cancers involve a loss of a protein called E-cadherin [9][10].

In a healthy stomach, E-cadherin acts as a molecular glue that keeps cells stuck together in an organized layer. In diffuse gastric cancer, the gene responsible for this glue (called CDH1) is often broken or turned off [11][12]. Without this glue, the cancer cells lose their cell adhesion (the ability to stick to one another) [13]. This allows them to break away and “crawl” through the deeper layers of the stomach wall, often moving under the surface where they are hidden from view during a standard endoscopy [14][15].

Signet Ring Cells

You may see the term signet ring cells on your pathology report. These are the hallmark cells of diffuse gastric cancer [16]. They look like tiny rings under a microscope because a large droplet of mucus pushes the cell’s nucleus (its control center) to one side [15].

Preventing Linitis Plastica

The goal of early intervention and treatment is to prevent the cancer from reaching an advanced state called linitis plastica [1].

In advanced cases, the diffuse spread of cancer cells triggers the body to produce thick, scarred tissue within the stomach wall. As the cancer cells and scar tissue build up, the stomach wall becomes very thick and rigid. In the past, doctors referred to this as “leather bottle stomach” because the stomach loses its ability to stretch and expand when you eat [1][17]. Linitis plastica is a serious sign that the cancer has spread extensively through the stomach layers, making treatment more complex [18].

Why Symptoms Are Often Overlooked

Because diffuse gastric cancer grows inside the stomach wall rather than as a lump on the surface, it is notoriously difficult to diagnose early.

Early Symptoms

Early signs are often vague and easy to mistake for common digestive issues, such as:

  • Indigestion or “heartburn” [1]
  • Mild nausea [1]
  • A feeling of being bloated after meals [19]

Advanced Symptoms

As the stomach wall thickens and stiffens, the symptoms become more specific:

  • Early Satiety: Feeling completely full after eating only a few bites of food [1].
  • Unexplained Weight Loss: Often due to the inability to eat full meals [20].
  • Vomiting: Occurs because the stomach can no longer move food properly into the intestines [1].

The Diagnostic Challenge

Because the surface of the stomach may look normal during an endoscopy, standard biopsies (taking small tissue samples from the surface) may come back “negative” or “normal” even if cancer is present underneath [14][21]. If your doctor suspects diffuse gastric cancer but a standard biopsy is negative, they may need to use Endoscopic Ultrasound (EUS) to look at the deeper layers of the stomach wall or perform a deeper biopsy [21][22].

Common questions in this guide

Why is diffuse gastric adenocarcinoma hard to diagnose?
Diffuse gastric cancer grows inside the layers of the stomach wall rather than forming a visible lump on the surface. Because the stomach lining often looks normal during a standard endoscopy, routine surface biopsies may miss the hidden cancer cells.
What are signet ring cells on my pathology report?
Signet ring cells are the hallmark feature of diffuse stomach cancer. They get their name because a large droplet of mucus inside the cell pushes its center to one side, making it look like a tiny ring under a microscope.
What does linitis plastica mean?
Linitis plastica is an advanced stage of diffuse gastric cancer where the stomach wall becomes thick and rigid from widespread cancer cells and scar tissue. This prevents the stomach from stretching when you eat, often causing you to feel full after just a few bites.
Should I get genetic testing if I have diffuse stomach cancer?
You may need genetic testing, especially if your pathology report shows a loss of the E-cadherin protein. Mutations in the CDH1 gene are strongly linked to this type of cancer, and testing can help identify risks for you and your family members.
What are the early signs of diffuse gastric adenocarcinoma?
Early signs are often vague and easy to mistake for common digestive problems, such as indigestion, mild nausea, and feeling bloated after meals. As the disease advances, symptoms like early fullness (satiety), vomiting, and unexplained weight loss become more noticeable.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What percentage of the tumor is made up of signet ring cells, and how does this affect my treatment plan?
  2. 2.Does my pathology report show a loss of E-cadherin expression?
  3. 3.Because diffuse gastric cancer can spread underneath the surface, how confident are you that the biopsies captured the full extent of the disease?
  4. 4.Based on my diagnosis, should I or my family members undergo genetic testing for the CDH1 mutation?
  5. 5.Was linitis plastica observed during my endoscopy or on my CT scan?
  6. 6.How does the 'diffuse' subtype change the likelihood that chemotherapy will be effective for me compared to the 'intestinal' type?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Beneath the Surface: Diagnosing Gastric Linitis Plastica.

    Marasini A, Delungahawatta T, Szeto B, et al.

    Journal of community hospital internal medicine perspectives 2024; (14(6)):124-127 doi:10.55729/2000-9666.1415.

    PMID: 39839172
  2. 2

    Odd localisation for a gastric cancer histology.

    Kuczma P, Vidal Fortuny J, Essia S, et al.

    International journal of surgery case reports 2016; (27()):51-54 doi:10.1016/j.ijscr.2016.07.028.

    PMID: 27543724
  3. 3

    Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer.

    Choi JK, Park YS, Jung DH, et al.

    Journal of gastric cancer 2015; (15(3)):183-90 doi:10.5230/jgc.2015.15.3.183.

    PMID: 26468416
  4. 4

    Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response.

    Abdelhakeem AA, Wang X, Waters RE, et al.

    Cancers 2021; (13(3)) doi:10.3390/cancers13030420.

    PMID: 33498613
  5. 5

    Clinicopathological Variation of Lauren Classification in Gastric Cancer.

    Chen YC, Fang WL, Wang RF, et al.

    Pathology oncology research : POR 2016; (22(1)):197-202 doi:10.1007/s12253-015-9996-6.

    PMID: 26502923
  6. 6

    NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori.

    Gonzalez-Hormazabal P, Pelaez D, Musleh M, et al.

    Biological research 2021; (54(1)):13 doi:10.1186/s40659-021-00336-4.

    PMID: 33879265
  7. 7

    High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.

    Ahn S, Lee SJ, Kim Y, et al.

    The American journal of surgical pathology 2017; (41(1)):106-115 doi:10.1097/PAS.0000000000000756.

    PMID: 27819872
  8. 8

    Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.

    Kao YC, Fang WL, Wang RF, et al.

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2019; (22(2)):255-263 doi:10.1007/s10120-018-0860-8.

    PMID: 30069742
  9. 9

    Prognosis and outcome in CDH1-mutant lobular breast cancer.

    Corso G, Veronesi P, Sacchini V, Galimberti V

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(3)):237-238 doi:10.1097/CEJ.0000000000000405.

    PMID: 29595757
  10. 10

    CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.

    Aitchison A, Hakkaart C, Whitehead M, et al.

    Pathology, research and practice 2020; (216(5)):152912 doi:10.1016/j.prp.2020.152912.

    PMID: 32147272
  11. 11

    Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch?

    Leclercq P, Jadot V, Bours V, et al.

    Therapeutic advances in gastroenterology 2020; (13()):1756284820916399 doi:10.1177/1756284820916399.

    PMID: 32523621
  12. 12

    Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.

    Moslim MA, Heald B, Tu C, et al.

    Surgery 2018; (164(4)):754-759 doi:10.1016/j.surg.2018.05.059.

    PMID: 30145018
  13. 13

    CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.

    Herrera-Pariente C, Bonjoch L, Muñoz J, et al.

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2024; (27(4)):747-759 doi:10.1007/s10120-024-01504-7.

    PMID: 38796558
  14. 14

    Endoscopic ultrasound-guided fine-needle aspiration biopsy for diagnosis of gastric linitis plastica with negative malignant endoscopy biopsies.

    Ye Y, Tan S

    Oncology letters 2018; (16(4)):4915-4920 doi:10.3892/ol.2018.9258.

    PMID: 30250557
  15. 15

    Hereditary diffuse gastric cancer: the evolution of a cancer syndrome.

    Decourtye-Espiard L, Godwin T, Guilford P

    Journal of the Royal Society of New Zealand 2025; (55(6)):2636-2651 doi:10.1080/03036758.2025.2511007.

    PMID: 40756848
  16. 16

    Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study.

    Li Y, Ma FH, Xue LY, Tian YT

    World journal of gastroenterology 2020; (26(8)):818-827 doi:10.3748/wjg.v26.i8.818.

    PMID: 32148379
  17. 17

    [68Ga]Ga-FAPI Versus [18F]FDG PET/CT in Signet Ring Cell Carcinoma with Linitis Plastica: Diagnostic Performance and Pitfalls.

    Agrawal R, Sitani K, Basu S

    Journal of nuclear medicine technology 2026; (54(1)):107-109 doi:10.2967/jnmt.125.270967.

    PMID: 41365647
  18. 18

    Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research.

    Deng ZJ, Nie RC, Lu J, et al.

    BMC gastroenterology 2021; (21(1)):363 doi:10.1186/s12876-021-01937-9.

    PMID: 34620108
  19. 19

    Jackhammer oesophagus in a case of linitis plastica.

    Chaudhry NA, Zahid K, Coman R, Zhang Q

    BMJ case reports 2016; (2016()).

    PMID: 27174454
  20. 20

    Gastric Metastasis Mimicking Linitis Plastica 20 Years after Primary Breast Cancer. A Case Report.

    Asmar N, Rey JF, Sattonnet C, Barriere J

    Journal of gastrointestinal and liver diseases : JGLD 2018; (27(4)):469-471 doi:10.15403/jgld.2014.1121.274.gas.

    PMID: 30574631
  21. 21

    Endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of gastric linitis plastica.

    Takahashi K, Yasuda I, Hanaoka T, et al.

    DEN open 2022; (2(1)):e38 doi:10.1002/deo2.38.

    PMID: 35310721
  22. 22

    Endoscopic ultrasound-guided fine-needle aspiration used in diagnosing gastric linitis plastica: Metastatic lymph nodes can be valuable targets.

    Liu Y, Chen K, Yang XJ

    Journal of gastroenterology and hepatology 2019; (34(1)):202-206 doi:10.1111/jgh.14300.

    PMID: 29864202

This page provides educational information about diffuse gastric adenocarcinoma. Always consult your gastroenterologist or oncologist for an accurate diagnosis and treatment plan tailored to your specific condition.

Get notified when new evidence is published on diffuse gastric adenocarcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.